Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 2883 of 5804
-
New group program aims to cut stroke risk in African-American men
Disease control CompletedThe project is a 6-month prospective Randomized Controlled Trial evaluating the effects of TargEted MAnageMent Intervention (TEAM, N=80) vs. wait-list (WL, N=80) control in African American men who have experienced a stroke or TIA within the past 5 years.
Phase: NA • Sponsor: Case Western Reserve University • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
Your tongue could reveal cancer: AI study analyzes 4,100 people
Knowledge-focused CompletedThe tongue images of malignant tumors and corresponding healthy people will be collected to establish the tongue image database. Deep learning will be carried out by computer and artificial intelligence to construct the early screening, diagnosis, prognosis and prognosis model of…
Sponsor: Zhejiang Cancer Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:02 UTC
-
Experimental drug targets hard-to-treat cancers with unique marker
Disease control CompletedA single arm phase II study with 30 patients of leronlimab (PRO 140) in patients with CCR5+ locally advanced or metastatic solid tumors.
Phase: PHASE2 • Sponsor: CytoDyn, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
New MRI technique could help men with prostate cancer avoid unnecessary treatment
Diagnosis ENROLLING_BY_INVITATIONTo investigate whether multiparametric MRI (mp-MRI) in patients with low-risk prostate cancer can improve the selection of patients suitable for Active Surveillance and have a relevance in the ongoing monitoring
Phase: NA • Sponsor: Herlev Hospital • Aim: Diagnosis
Last updated Jun 26, 2026 16:01 UTC
-
Smart sensors could revolutionize rehab for amputees
Symptom relief OngoingThe goal of this research is to analyze data from smartphone-based and wearable sensors, using advanced machine-learning and data-mining techniques, and to combine this information with performance-based measures, participant-reported measures, and structured interviews to create…
Phase: NA • Sponsor: Shirley Ryan AbilityLab • Aim: Symptom relief
Last updated Jun 27, 2026 08:08 UTC
-
Scientists launch major effort to track rare nerve disease in children
Knowledge-focused Recruiting nowThe Registry and Natural History Study for Early Onset Hereditary Spastic Paraplegia (HSP) is focused on gathering longitudinal clinical data as well as biological samples (skin and/or blood and/or saliva) from male and female patients, under the age of 30, who exhibited early on…
Sponsor: Boston Children's Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:02 UTC
-
Healthcare workers under the microscope: tracking COVID-19 spread and immunity
Knowledge-focused CompletedThe main objectives of this study are 1) to establish the prevalence of SARS-CoV-2 in asymptomatic healthcare workers (HCWs) in an early phase of community spread as well as 2) to monitor the future spread of the disease by assessing serological responses to SARS-CoV-2 in symptom…
Sponsor: University Medicine Greifswald • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:59 UTC
-
New antibody drug takes on Hard-to-Treat cancers
Disease control CompletedThis is a Phase 1/1b, open-label, first-in-human, dose-escalation and expansion study of CHS-388, a monoclonal antibody that targets IL-27, as a monotherapy and in combination in patients with solid tumors.
Phase: PHASE1 • Sponsor: Coherus Oncology, Inc. • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
Healthcare Workers' COVID antibodies under the microscope
Knowledge-focused Recruiting nowThe novel coronavirus (SARS-CoV-2) has spread all around the world and testing has posed a challenge globally. Health care providers are highly exposed and are an important group to test. On top of these concerns, health care workers are also stressed by the needs on responders i…
Sponsor: Columbia University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:05 UTC
-
Strasbourg hospital staff antibody study reveals infection spread
Knowledge-focused CompletedCOVID-19 is a new emerging disease caused by infection with the SARS-CoV-2 coronavirus, with no specific therapeutic options. Since the end of February 2020, the Strasbourg University Hospital (HUS) had faced a sudden increase of patients with COVID-19 resulted from a SARS-CoV-2…
Phase: NA • Sponsor: University Hospital, Strasbourg, France • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:12 UTC
-
Ebola survivors under the microscope: what happens after recovery?
Knowledge-focused CompletedEbola virus is one of the most dangerous human pathogens and is an emerging public health problem in sub-Saharan Africa. Ebola virus disease (EVD) first appeared in 1976. The current epidemic in the Democratic Republic of the Congo (DRC) is one of the largest and most complex eve…
Sponsor: Institut National de la Santé Et de la Recherche Médicale, France • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:52 UTC
-
Lung cancer & COVID: new study tracks immune response in nearly 2,000 patients
Knowledge-focused CompletedObservational, retrospective data collection and prospective IgG analysis, and multicenter study. The main objective of the study is th description of the characteristics and evolution of patients with lung cancer who have acquired COVID-19 infection. For the identification of …
Sponsor: Fundación GECP • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:03 UTC
-
New pain block may reduce opioid use in kids after hip surgery
Symptom relief CompletedSurgical repair of the hip can be extremely painful and is associated with considerable postoperative pain in children despite the use of systemic opioids. These patients may benefit from neuraxial analgesia in adjunction with general anesthesia. The reported advantages of this t…
Phase: NA • Sponsor: Tanta University • Aim: Symptom relief
Last updated Jun 27, 2026 12:31 UTC
-
Kefir peptides show promise for fracture healing in small study
Disease control CompletedThis study is designed to evaluate the effects of kefir-derived peptides on bone healing in patients with upper limb fractures. Kefir peptides are natural protein fragments that may promote bone formation and reduce inflammation. Participants with recent upper limb fractures will…
Phase: NA • Sponsor: Jen-Chieh Lai • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Video therapy boosts autism communication at home
Symptom relief CompletedThere is an urgent need for improved access to effective autism treatments. With advances in technology, distance learning models have particular promise for families who cannot access evidence-based parent training locally or may be on long wait-lists for behavioral treatments. …
Phase: NA • Sponsor: Stanford University • Aim: Symptom relief
Last updated Jun 27, 2026 07:58 UTC
-
New hope for Tough-to-Treat myeloma: early safety trial of HPN217 begins
Disease control OngoingResearchers want to learn if MK-4002 (also known as HPN217) can treat relapsed or refractory multiple myeloma (RRMM). The goals of this study are to learn about the safety of different doses of MK-4002 and how well people tolerate them. Researchers also want to learn what happens…
Phase: PHASE1 • Sponsor: Harpoon Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) • Aim: Disease control
Last updated Jun 27, 2026 08:02 UTC
-
Cancer combo trial halted before full results
Disease control TerminatedAn ascending dose study in patients with solid tumors to evaluate the safety, tolerability, pharmacodynamics and efficacy of APG-1387 in combination with toripalimab. A phase II study of 3 cohorts will be included.
Phase: PHASE1, PHASE2 • Sponsor: Ascentage Pharma Group Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
New hope for essential thrombocythemia patients: experimental drug targets overactive platelet production
Disease control OngoingThis is a single-center, open-label investigator-initiated trial evaluating the effects of IMG-7289 administered orally once daily in patients with essential thrombocythemia.
Phase: PHASE2 • Sponsor: The University of Texas Health Science Center at San Antonio • Aim: Disease control
Last updated Jun 26, 2026 15:31 UTC
-
COVID-19's skin secrets: could chilblains hold clues to the virus?
Knowledge-focused Recruiting nowSome patients infected by covid-19 develop skin manifestations. These manifestations are still not well known and there pathophysiology remain unclear. Among them, acral manifestation resembling to chilblains appears frequent and quite specific. The aim of this project is to bett…
Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Knowledge-focused
Last updated Jul 01, 2026 00:00 UTC
-
Cialis and keytruda together against head and neck cancer: small trial shows promise?
Disease control CompletedThis study will examine the combination of pembrolizumab and tadalafil for safety and efficacy in advanced head and neck cancer.
Phase: PHASE2 • Sponsor: University of California, San Diego • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC